216 related articles for article (PubMed ID: 15731168)
1. Evolution of intratumoral genetic heterogeneity during colorectal cancer progression.
Losi L; Baisse B; Bouzourene H; Benhattar J
Carcinogenesis; 2005 May; 26(5):916-22. PubMed ID: 15731168
[TBL] [Abstract][Full Text] [Related]
2. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral heterogeneity of genetic changes in primary colorectal carcinomas with metastasis.
Fukunari H; Iwama T; Sugihara K; Miyaki M
Surg Today; 2003; 33(6):408-13. PubMed ID: 12768365
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
5. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms.
Fujii H; Ajioka Y; Kazami S; Takagaki T; Gong Zhu X; Hirose S; Watanabe H; Shirai T
J Pathol; 2002 Jul; 197(3):298-306. PubMed ID: 12115875
[TBL] [Abstract][Full Text] [Related]
7. Telomeric repeat-length alterations in colorectal carcinoma are associated with loss of heterozygosity and point mutation in p53 gene.
Ohki S; Onda M; Fukushima T; Takita K; Suzuki S; Hoshino M; Tsuchiya A; Abe R; Takenoshita S
Int J Mol Med; 2003 Apr; 11(4):485-90. PubMed ID: 12632102
[TBL] [Abstract][Full Text] [Related]
8. Sex chromosome alterations associate with tumor progression in sporadic colorectal carcinomas.
Bottarelli L; Azzoni C; Necchi F; Lagrasta C; Tamburini E; D'Adda T; Pizzi S; Sarli L; Rindi G; Bordi C
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4365-70. PubMed ID: 17671117
[TBL] [Abstract][Full Text] [Related]
9. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma.
Baisse B; Bouzourene H; Saraga EP; Bosman FT; Benhattar J
Int J Cancer; 2001 Aug; 93(3):346-52. PubMed ID: 11433398
[TBL] [Abstract][Full Text] [Related]
10. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
12. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma.
Lagerstedt KK; Kressner U; Lönnroth C; Nordgren S; Lundholm K
Int J Oncol; 2005 Dec; 27(6):1707-15. PubMed ID: 16273227
[TBL] [Abstract][Full Text] [Related]
13. Assessment of K-ras, Smad4 and p53 gene alterations in colorectal metastases and their role in the metastatic process.
Losi L; Luppi G; Benhattar J
Oncol Rep; 2004 Dec; 12(6):1221-5. PubMed ID: 15547741
[TBL] [Abstract][Full Text] [Related]
14. Frequent occurrence of uniparental disomy in colorectal cancer.
Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract.
Pizzi S; Azzoni C; Bassi D; Bottarelli L; Milione M; Bordi C
Cancer; 2003 Sep; 98(6):1273-82. PubMed ID: 12973852
[TBL] [Abstract][Full Text] [Related]
16. [Genetic heterogeneity of certain sporadic colorectal cancers].
Vincent-Salomon A; Olschwang S; Hamelin R; Remvikos Y; Laurent-Puig P; Thomas G
Gastroenterol Clin Biol; 1993; 17(10):733-9. PubMed ID: 8288082
[TBL] [Abstract][Full Text] [Related]
17. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
18. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
19. Resistance to DNA-damaging agents is discordant from experimental metastatic capacity in MEF ras-transformants-expressing gain of function MTp53.
Bristow RG; Peacock J; Jang A; Kim J; Hill RP; Benchimol S
Oncogene; 2003 May; 22(19):2960-6. PubMed ID: 12771947
[TBL] [Abstract][Full Text] [Related]
20. Genomic heterogeneity and instability in colorectal cancer: spectral karyotyping, glutathione transferase-Ml and ras.
Bartos JD; Stoler DL; Matsui S; Swede H; Willmott LJ; Sait SN; Petrelli NJ; Anderson GR
Mutat Res; 2004 Dec; 568(2):283-92. PubMed ID: 15542115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
